0

Gastrointestinal Bleeding Treatment Market by Product and Geography - Forecast and Analysis 2022-2026

  • Published: Mar 2022
  • Pages: 129
  • SKU: IRTNTR72994
Technavio

Purchase this report now and if we publish a new version within 90 days, we will send you a free copy.

Safe and Secure SSL Encrypted
  • 2500.00
  • USD

The gastrointestinal bleeding treatment market share is expected to increase by USD 188.19 million from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 4.63%.

This gastrointestinal bleeding treatment market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers gastrointestinal bleeding treatment market segmentation by product (endoscopic mechanical devices, endoscopic thermal devices, and others) and geography (North America, Europe, Asia, and Rest of World (ROW)). The gastroenterology market size report also offers information on several market vendors, including Boston Scientific Corp., Conmed Corp., Cook Group Inc., EndoClot Plus Inc., Erbe Elektromedizin GmbH, Mayo Foundation for Medical Education and Research, Medtronic Plc, Olympus Corp., OVESCO ENDOSCOPY AG, STERIS Plc, and University Hospitals among others.

What will the Gastrointestinal Bleeding Treatment Market Size be During the Forecast Period?

Download the Free Report Sample to Unlock the Gastrointestinal Bleeding Treatment Market Size for the Forecast Period and Other Important Statistics

 

Gastrointestinal Bleeding Treatment Market: Key Drivers, Trends, and Challenges

The favorable initiatives and increasing prevalence of gastrointestinal diseases is notably driving the gastrointestinal bleeding treatment market growth, although factors such as high treatment costs may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the gastrointestinal bleeding treatment industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.

Key Gastrointestinal Bleeding Treatment Market Driver

One of the key factors driving the global gastrointestinal bleeding treatment market growth is the favorable initiatives and increasing prevalence of gastrointestinal diseases. The increasing prevalence of esophageal, colorectal, gastric cancers, and colon polyps will further augment the growth of the market. For instance, as per the CDC, about 3.5 million adults were screened for colorectal cancer in 2018. Similarly, awareness about GI bleeding increased among physicians and patients has increased over the last few years.  In addition, various countries such as the US, Germany, and the UK have implemented screening initiatives. Moreover, governments, private institutions, and leading vendors have intensified their awareness campaigns for gastrointestinal diseases. For instance, Olympus, a key market vendor, has designated the month of March every year as Colon Cancer Awareness Month and organizes various awareness programs. Such factors will boost the market growth in the forecast period.

Key Gastrointestinal Bleeding Treatment Market Trend

Funding for GI research studies and endoscopic devices is one of the key gastrointestinal bleeding treatment market trends that is expected to impact the industry positively in the forecast period. For instance, in 2019, the American College of Gastroenterology (ACG), Institute for Clinical Research and Education awarded USD 1,007,420 to support clinical research in gastroenterology. In 2017-2018, the National Institute for Health Research (NIHR) invested USD 17.89mn in research studies on gastrointestinal conditions. In addition, in June 2019, the National Science Foundation (NSF), an independent federal agency created by Congress, granted an award of USD 225,000 for the Small Business Innovation Research (SBIR) Phase I project, for clinical needs of tissue approximation and closure of large gastrointestinal defects in endoscopic surgeries by developing image-guided, full-thickness suturing devices. Such factors will further support the market growth in the coming years.

Key Gastrointestinal Bleeding Treatment Market Challenge

One of the key challenges to the global gastrointestinal bleeding treatment market growth is the high treatment costs. This makes market penetration difficult, especially in price-sensitive markets such as developing and emerging economies. Even in developed countries, small hospitals and private physician's clinics may not opt for endoscopic kits due to budget constraints. Equipment maintenance is another factor that adds to the financial burden of end-users. Surgeons in developing and emerging countries are still reluctant to choose endoscopic surgeries owing to their high price. Advances in endoscopic procedures have increased the prices of endoscopic systems, making treatments unaffordable for most patients in developing economies. The high cost of the procedure and lack of reimbursement in developing economies will hamper the growth of the market during the forecast period.

This gastrointestinal bleeding treatment market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.

Parent Market Analysis

Technavio categorizes the global gastrointestinal bleeding treatment market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the gastrointestinal bleeding treatment market during the forecast period.

Who are the Major Gastrointestinal Bleeding Treatment Market Vendors?

The report analyzes the market’s competitive landscape and offers information on several market vendors, including:

 

  • Boston Scientific Corp.
  • Conmed Corp.
  • Cook Group Inc.
  • EndoClot Plus Inc.
  • Erbe Elektromedizin GmbH
  • Mayo Foundation for Medical Education and Research
  • Medtronic Plc
  • Olympus Corp.
  • OVESCO ENDOSCOPY AG
  • STERIS Plc
  • University Hospitals

 

This statistical study of the gastrointestinal bleeding treatment market encompasses successful business strategies deployed by the key vendors. The gastrointestinal bleeding treatment market is fragmented and the vendors are deploying growth strategies such as investment in research and development (R and D) to compete in the market.

Product Insights and News

  • Boston Scientific Corp. - The company offers gastrointestinal bleeding treatment that includes polypectomy, retrieval devices band ligator, clips, endoluminal surgery devices, enteral access and feeding tubes, fiducial markers, forceps, guidewires. 
  • Boston Scientific Corp. - In January 2021, the company announced that it had entered into a definitive agreement to acquire Preventice Solutions Inc. 

To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.

The gastrointestinal bleeding treatment market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.

Gastrointestinal Bleeding Treatment Market Value Chain Analysis

Our report provides extensive information on the value chain analysis for the gastrointestinal bleeding treatment market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.

Which are the Key Regions for Gastrointestinal Bleeding Treatment Market?

For more insights on the market share of various regions Request for a FREE sample now!

42% of the market’s growth will originate from North America during the forecast period. The US is the key market for gastrointestinal bleeding treatment in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW.

The high adoption of technology, increasing prevalence and incidences of GI diseases, growing geriatric population, and the growing presence of prominent vendors that develop endoscopic devices will facilitate the gastrointestinal bleeding treatment market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.

COVID Impact and Recovery Analysis

However, in 2020, the outbreak of the COVID-19 pandemic mainly impacted the market in the US, which resulted in a decline in the growth rate of the market due to the implication of lockdowns and altered international trading. However, with the onset of vaccination drives in 2021, the market is expected to regain growth during the forecast period

What are the Revenue-generating Product Segments in the Gastrointestinal Bleeding Treatment Market?

To gain further insights on the market contribution of various segments Request for a FREE sample

The gastrointestinal bleeding treatment market share growth by the endoscopic mechanical devices segment will be significant during the forecast period. The growth is attributed to the high demand for endoscopic mechanical devices due to the increase in usage of these devices for the treatment of bleeding in the upper GI tract, as well as the increased preference for minimally invasive surgeries. This segment sees continuous product improvements and enhancements as well as the introduction of innovative products by vendors.

This report provides an accurate prediction of the contribution of all the segments to the growth of the gastrointestinal bleeding treatment market size and actionable market insights on post COVID-19 impact on each segment.

 

Gastrointestinal Bleeding Treatment Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 4.63%

Market growth 2022-2026

$ 188.19 million

Market structure

Fragmented

YoY growth (%)

3.73

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 42%

Key consumer countries

US, Germany, UK, China, and Japan

Competitive landscape

Leading companies, Competitive strategies, Consumer engagement scope

Key companies profiled

Boston Scientific Corp., Conmed Corp., Cook Group Inc., EndoClot Plus Inc., Erbe Elektromedizin GmbH, Mayo Foundation for Medical Education and Research, Medtronic Plc, Olympus Corp., OVESCO ENDOSCOPY AG, STERIS Plc, and University Hospitals

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request for a FREE sample

What are the Key Data Covered in this Gastrointestinal Bleeding Treatment Market Report?

  • CAGR of the market during the forecast period 2022-2026
  • Detailed information on factors that will drive gastrointestinal bleeding treatment market growth during the next five years
  • Precise estimation of the gastrointestinal bleeding treatment market size and its contribution to the parent market
  • Accurate predictions on upcoming trends and changes in consumer behavior
  • The growth of the gastrointestinal bleeding treatment industry across North America, Europe, Asia, and Rest of World (ROW)
  • A thorough analysis of the market’s competitive landscape and detailed information on vendors
  • Comprehensive details of factors that will challenge the growth of gastrointestinal bleeding treatment market vendors

We can help! Our analysts can customize this report to meet your requirements. Get in touch

Read More Read Less

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
    • 3.4 Market outlook: Forecast for 2021-2026
      • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
      • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
      • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

    4 Five Forces Analysis

    • 4.1 Five forces summary
      • Exhibit 17: Five forces analysis - Comparison between2021 and 2026
    • 4.2 Bargaining power of buyers
      • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
    • 4.3 Bargaining power of suppliers
      • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
    • 4.4 Threat of new entrants
      • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
    • 4.5 Threat of substitutes
      • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
    • 4.6 Threat of rivalry
      • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
    • 4.7 Market condition
      • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

    5 Market Segmentation by Product

    • 5.1 Market segments
      • Exhibit 24: Chart on Product - Market share 2021-2026 (%)
      • Exhibit 25: Data Table on Product - Market share 2021-2026 (%)
    • 5.2 Comparison by Product
      • Exhibit 26: Chart on Comparison by Product
      • Exhibit 27: Data Table on Comparison by Product
    • 5.3 Endoscopic mechanical devices - Market size and forecast 2021-2026
      • Exhibit 28: Chart on Endoscopic mechanical devices - Market size and forecast 2021-2026 ($ million)
      • Exhibit 29: Data Table on Endoscopic mechanical devices - Market size and forecast 2021-2026 ($ million)
      • Exhibit 30: Chart on Endoscopic mechanical devices - Year-over-year growth 2021-2026 (%)
      • Exhibit 31: Data Table on Endoscopic mechanical devices - Year-over-year growth 2021-2026 (%)
    • 5.4 Endoscopic thermal devices - Market size and forecast 2021-2026
      • Exhibit 32: Chart on Endoscopic thermal devices - Market size and forecast 2021-2026 ($ million)
      • Exhibit 33: Data Table on Endoscopic thermal devices - Market size and forecast 2021-2026 ($ million)
      • Exhibit 34: Chart on Endoscopic thermal devices - Year-over-year growth 2021-2026 (%)
      • Exhibit 35: Data Table on Endoscopic thermal devices - Year-over-year growth 2021-2026 (%)
    • 5.5 Others - Market size and forecast 2021-2026
      • Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
      • Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
      • Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
    • 5.6 Market opportunity by Product
      • Exhibit 40: Market opportunity by Product ($ million)

    6 Customer Landscape

    • 6.1 Customer landscape overview
      • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    7 Geographic Landscape

    • 7.1 Geographic segmentation
      • Exhibit 42: Chart on Market share by geography 2021-2026 (%)
      • Exhibit 43: Data Table on Market share by geography 2021-2026 (%)
    • 7.2 Geographic comparison
      • Exhibit 44: Chart on Geographic comparison
      • Exhibit 45: Data Table on Geographic comparison
    • 7.3 North America - Market size and forecast 2021-2026
      • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
      • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
      • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
    • 7.4 Europe - Market size and forecast 2021-2026
      • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
      • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
      • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
    • 7.5 Asia - Market size and forecast 2021-2026
      • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
      • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
      • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
    • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
      • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
      • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
      • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
    • 7.7 US - Market size and forecast 2021-2026
      • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
      • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
      • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
    • 7.8 Germany - Market size and forecast 2021-2026
      • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
      • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
      • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
    • 7.9 UK - Market size and forecast 2021-2026
      • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
      • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
      • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
    • 7.10 China - Market size and forecast 2021-2026
      • Exhibit 74: Chart on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 75: Data Table on China - Market size and forecast 2021-2026 ($ million)
      • Exhibit 76: Chart on China - Year-over-year growth 2021-2026 (%)
      • Exhibit 77: Data Table on China - Year-over-year growth 2021-2026 (%)
    • 7.11 Japan - Market size and forecast 2021-2026
      • Exhibit 78: Chart on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 79: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
      • Exhibit 80: Chart on Japan - Year-over-year growth 2021-2026 (%)
      • Exhibit 81: Data Table on Japan - Year-over-year growth 2021-2026 (%)
    • 7.12 Market opportunity by geography
      • Exhibit 82: Market opportunity by geography ($ million)

    8 Drivers, Challenges, and Trends

    • 8.1 Market drivers
      • 8.2 Market challenges
        • 8.3 Impact of drivers and challenges
          • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
        • 8.4 Market trends

          9 Vendor Landscape

          • 9.1 Overview
            • 9.2 Vendor landscape
              • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
            • 9.3 Landscape disruption
              • Exhibit 85: Overview on factors of disruption
            • 9.4 Industry risks
              • Exhibit 86: Impact of key risks on business

            10 Vendor Analysis

            • 10.1 Vendors covered
              • Exhibit 87: Vendors covered
            • 10.2 Market positioning of vendors
              • Exhibit 88: Matrix on vendor position and classification
            • 10.3 Boston Scientific Corp.
              • Exhibit 89: Boston Scientific Corp. - Overview
              • Exhibit 90: Boston Scientific Corp. - Business segments
              • Exhibit 91: Boston Scientific Corp. - Key news
              • Exhibit 92: Boston Scientific Corp. - Key offerings
              • Exhibit 93: Boston Scientific Corp. - Segment focus
            • 10.4 Conmed Corp.
              • Exhibit 94: Conmed Corp. - Overview
              • Exhibit 95: Conmed Corp. - Business segments
              • Exhibit 96: Conmed Corp. - Key offerings
              • Exhibit 97: Conmed Corp. - Segment focus
            • 10.5 Cook Group Inc.
              • Exhibit 98: Cook Group Inc. - Overview
              • Exhibit 99: Cook Group Inc. - Product / Service
              • Exhibit 100: Cook Group Inc. - Key offerings
            • 10.6 Erbe Elektromedizin GmbH
              • Exhibit 101: Erbe Elektromedizin GmbH - Overview
              • Exhibit 102: Erbe Elektromedizin GmbH - Product / Service
              • Exhibit 103: Erbe Elektromedizin GmbH - Key offerings
            • 10.7 Mayo Foundation for Medical Education and Research
              • Exhibit 104: Mayo Foundation for Medical Education and Research - Overview
              • Exhibit 105: Mayo Foundation for Medical Education and Research - Product / Service
              • Exhibit 106: Mayo Foundation for Medical Education and Research - Key offerings
            • 10.8 Medtronic Plc
              • Exhibit 107: Medtronic Plc - Overview
              • Exhibit 108: Medtronic Plc - Business segments
              • Exhibit 109: Medtronic Plc - Key news
              • Exhibit 110: Medtronic Plc - Key offerings
              • Exhibit 111: Medtronic Plc - Segment focus
            • 10.9 Olympus Corp.
              • Exhibit 112: Olympus Corp. - Overview
              • Exhibit 113: Olympus Corp. - Business segments
              • Exhibit 114: Olympus Corp. - Key news
              • Exhibit 115: Olympus Corp. - Key offerings
              • Exhibit 116: Olympus Corp. - Segment focus
            • 10.10 OVESCO ENDOSCOPY AG
              • Exhibit 117: OVESCO ENDOSCOPY AG - Overview
              • Exhibit 118: OVESCO ENDOSCOPY AG - Product / Service
              • Exhibit 119: OVESCO ENDOSCOPY AG - Key offerings
            • 10.11 STERIS Plc
              • Exhibit 120: STERIS Plc - Overview
              • Exhibit 121: STERIS Plc - Business segments
              • Exhibit 122: STERIS Plc - Key news
              • Exhibit 123: STERIS Plc - Key offerings
              • Exhibit 124: STERIS Plc - Segment focus
            • 10.12 University Hospitals
              • Exhibit 125: University Hospitals - Overview
              • Exhibit 126: University Hospitals - Product / Service
              • Exhibit 127: University Hospitals - Key offerings

            11 Appendix

            • 11.1 Scope of the report
              • 11.2 Inclusions and exclusions checklist
                • Exhibit 128: Inclusions checklist
                • Exhibit 129: Exclusions checklist
              • 11.3 Currency conversion rates for US$
                • Exhibit 130: Currency conversion rates for US$
              • 11.4 Research methodology
                • Exhibit 131: Research methodology
                • Exhibit 132: Validation techniques employed for market sizing
                • Exhibit 133: Information sources
              • 11.5 List of abbreviations
                • Exhibit 134: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              TechnavioINFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases
              Technavio

              TechnavioDATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts
              Technavio

              TechnavioREPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape
              Interested in this report?
              Get your FREE sample now!
              The gastrointestinal bleeding treatment market growth will increase by $188.19 million during 2022-2026.
              The gastrointestinal bleeding treatment market is expected to grow at a CAGR of 4.63% during 2022-2026.
              Technavio has segmented the gastrointestinal bleeding treatment market by product (Endoscopic mechanical devices, Endoscopic thermal devices, and Others) and geographic (North America, Europe, Asia, and Rest of World (ROW)).
              Boston Scientific Corp., Conmed Corp., Cook Group Inc., EndoClot Plus Inc., Erbe Elektromedizin GmbH, Mayo Foundation for Medical Education and Research, Medtronic Plc, Olympus Corp., OVESCO ENDOSCOPY AG, STERIS Plc, University Hospitals are a few of the key vendors in the gastrointestinal bleeding treatment market.
              North America will register the highest growth rate of 41.68% among the other regions. Therefore, the gastrointestinal bleeding treatment market in North America is expected to garner significant business opportunities for the vendors during the forecast period.
              The key factors driving the gastrointestinal bleeding treatment market growth are:
              • Favorable initiatives and increasing prevalence of gastrointestinal diseases
              • Funding for GI research studies and endoscopic devices
              The gastrointestinal bleeding treatment market vendors should focus on grabbing business opportunities from the endoscopic mechanical devices segment as it accounted for the largest market share in the base year.
              Safe and Secure SSL Encrypted
              Technavio

              Single User:

              2500 USD

              Technavio Get the report (PDF) sent to your email within minutes.

              Subscribe & Save

              Get lifetime access to our
              Technavio Insights

              Want to customize this report?

              This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.

              We offer $1000 worth of FREE customization at the time of purchase
              Technavio
              Enquire Before Buying
              1. Home
              2. Health Care
              3. Published Report
              17,000 reports available | Plans starting from just 5,000 USD | Get FREE trial>>